PGIM Nasdaq-100 Buffer 12 ETF – October (NASDAQ:PQOC – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totaling 13,650 shares, a growth of 69.1% from the September 30th total of 8,074 shares. Based on an average trading volume of 7,338 shares, the days-to-cover ratio is currently 1.9 days. Currently, 1.5% of the company’s stock are sold short.
PGIM Nasdaq-100 Buffer 12 ETF – October Stock Up 0.4%
Shares of PQOC opened at $31.29 on Tuesday. PGIM Nasdaq-100 Buffer 12 ETF – October has a 52-week low of $27.15 and a 52-week high of $32.96. The business’s 50 day moving average is $32.11 and its two-hundred day moving average is $30.45. The firm has a market cap of $28.47 million, a price-to-earnings ratio of 31.60 and a beta of 0.73.
Hedge Funds Weigh In On PGIM Nasdaq-100 Buffer 12 ETF – October
A hedge fund recently raised its stake in PGIM Nasdaq-100 Buffer 12 ETF – October stock. NewEdge Advisors LLC grew its holdings in shares of PGIM Nasdaq-100 Buffer 12 ETF – October (NASDAQ:PQOC – Free Report) by 25.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,740 shares of the company’s stock after buying an additional 2,779 shares during the period. NewEdge Advisors LLC owned 2.25% of PGIM Nasdaq-100 Buffer 12 ETF – October worth $381,000 as of its most recent filing with the Securities and Exchange Commission.
PGIM Nasdaq-100 Buffer 12 ETF – October Company Profile
The PGIM Nasdaq-100 Buffer 12 ETF – October (PQOC) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the Invesco QQQ Trust over a specific holdings period. The actively managed fund holds FLEX options. PQOC was launched on Dec 27, 2024 and is issued by PGIM.
See Also
- Five stocks we like better than PGIM Nasdaq-100 Buffer 12 ETF – October
- SpaceX Starlink’s Telecom Ground Game Takes Shape
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
Receive News & Ratings for PGIM Nasdaq-100 Buffer 12 ETF - October Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PGIM Nasdaq-100 Buffer 12 ETF - October and related companies with MarketBeat.com's FREE daily email newsletter.
